PTO/SB/O8a (01-10)
`Doc code: IDS
`Approvedfor use through 07/31/2012. OMB 0651-0031
`‘
`.
`.
`ve
`U.S.Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE
`Docdescription: Information Disclosure Statement (IDS) Filed
`Under the Paperwork Reduction Act of 1995, no persons are required to respend to a collection of information unless it contains a valid OMB control number.
`
`Application Number
`
`14210572
`
`
`
`
`
`
`
`
`Filing Date
`2014-03-14
`
`
`INFORMATION DISCLOSURE First Named Inventor|Fernando Di Caprio
`
`STATEMENT BY APPLICANT [|
`|
`
`
`
`
`
`
`
`
`
`
`
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`Attorney Docket Number
`
`8969683/2
`
`U.S.PATENTS
`Remove
`
`
`.
`Pages,Columns,Lines where
`.
`.
`.
`Name of Patentee or Applicant Relevant Passages or Relevant
`Issue Date
`Kind
`Patent Number
`Examiner Cite
`.
`of cited Document
`Code’
`No
`Initial
`Figures Appear
`
`
`1
`
`2
`
`4581017
`
`1986-04-08
`
`Sahota
`
`5385562
`
`1995-01-31
`
`Adams
`
`
`
`3
`
`4
`
`5439445
`
`1995-08-08
`
`Kontos
`
`5290247
`
`1994-03-01
`
`Crittendon
`
`
`
`5
`
`6
`
`7
`
`8048032
`
`2011-11-01
`
`Rootetal.
`
`8142413
`
`2012-03-27
`
`Rootet al.
`
`8292850
`
`2012-10-23
`
`Rootetal.
`
`If you wish te add additional U.S. Patentcitation information please click the Add button.
`U.S.PATENT APPLICATION PUBLICATIONS
`
`Add
`Remove
`
`EFS Web2.1.17
`
`Page 1
`
`Teleflex Ex. 2196
`Medtronicv. Teleflex
`
`
`Page 1
`
`Teleflex Ex. 2196
`Medtronic v. Teleflex
`
`

`

`
`
`14210572
`
`
`
`
`
`
` Application Number
`
`2014-03-14
`Filing Date
`INFORMATION DISCLOSURE
`
`First Named Inventer|Fernando Di Caprio
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
` Examiner Name
`Attorney Docket Number
`
`| 896968312
`
`
`
`
`
`Include copy of this form with next communication to applicant.
`
`
`
`
`
`
`
`
`
`
`Examiner}
`
`Initial”
`
`Cite No
`
`Publication
`Number
`
`Kind
`Code’
`
`Publication
`Date
`
`Pages,Columns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`Nameof Patentee or Applicant
`
`of cited Document
`
`If you wish to add additional U.S. Published Application citation information please click the Add button. Add
`FOREIGN PATENT DOCUMENTS Remove
`
`
`Pages,Columns,Lines
`Nameof Patentee or where Relevant
`Publication
`Kind
`5
`Country
`Examiner} Cite|Foreign Document
`Code2 |
`q
`Applicantof cited
`Initial” DateCode4No|Number3
`
`
`
`Passages or Relevant
`Document
`
`Figures Appear
`
`Add
`If you wish to add additional Foreign Patent Documentcitation information please click the Add button
`Remove
`NON-PATENT LITERATURE DOCUMENTS
`
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item
`Examiner! Cite
`(book, magazine,journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`Initials*
`
`publisher, city and/or country where published.
`
`
`
`If you wish to add additional non-patentliterature documentcitation information pleaseclick the Add button Add
`EXAMINER SIGNATURE
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial numberof the patent document.
`4 Kind of documentby the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible.
`5 Applicant is to place a check mark hereif]
`English languagetranslation is attached.
`
`EFS Web 2.1.17
`
`Page 2
`
`Teleflex Ex. 2196
`
`Medtronic v. Teleflex
`
`
`Page 2
`
`Teleflex Ex. 2196
`Medtronic v. Teleflex
`
`

`

`
`
`
`14210572
`Application Number
`
`2014-03-14
`Filing Date
`INFORMATION DISCLOSURE
`
`First Named Inventer|Fernando Di Caprio
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
` Examiner Name
`Attorney Docket Number
`
`
`
`| 896968312
`
`
`
`
`
`
`
`
`
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`[_]
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to thefiling of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c} more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e}(2).
`
`[|
`
`
`
`
`[_] See attached certification statement.
`[|
`Thefee setforth in 37 CFR 1.17 (p) has been submitted herewith.
`[xX] Acertification statementis not submitted herewith.
`
`SIGNATURE
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d} for the
`form of the signature.
`
`
`
`Signature
`
`Name/Print
`
`/Sean D. Solberg, Reg. No. 48653/
`
`Date (YYYY-MM-DD)
`
`2014-07-02
`
`Sean D. Solberg
`
`Registration Number
`
`48653
`
`
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public whichis to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amountof time you
`require to complete this form and/or suggestions for reducing this burden, should be sentto the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`Page 3
`
`Teleflex Ex. 2196
`Medtronic v. Teleflex
`
`
`Page 3
`
`Teleflex Ex. 2196
`Medtronic v. Teleflex
`
`

`

`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1} the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and TrademarkOffice is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these record s.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`requestinvolving an individual, to whom the record pertains, when the individual has requested assistance from the
`Memberwith respectto the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA aspart of that agency's responsibility to
`recommend improvements in records managementpractices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant(i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record wasfiled in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced byeither a published application, an application open to public inspections or an issued patent.
`
`3.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes awareof a violation or potential violation of law or regulation.
`
`
`
`EFS Web 2.1.17
`
`Page 4
`
`Teleflex Ex. 2196
`Medtronicv. Teleflex
`
`
`Page 4
`
`Teleflex Ex. 2196
`Medtronic v. Teleflex
`
`